Adaptimmune Ltd.
57c Milton Park
Abingdon
Oxfordshire
OX14 4RX
United Kingdom
Tel: +44-(0)-1235-438-642
Fax: +44-(0)-1235-438-607
Website: http://www.adaptimmune.com/
131 articles about Adaptimmune Ltd.
-
Adaptimmune Ltd. Appoints Dr. Jonathan Knowles As Chairman Of The Board
11/20/2013
-
Adaptimmune Ltd. Announces Opening of Phase I/IIa Clinical Trial in Ovarian Cancer
7/25/2013
-
Adaptimmune Ltd. Selects SCiAN Services' EDC(PRO) Solution to Support a Series of Clinical Trials Starting in 2013
2/12/2013
-
NeoStem, Inc.'s Subsidiary, Progenitor Cell Therapy, Enters Into a Cell Therapy Manufacturing Services Agreement With Adaptimmune Ltd.
1/22/2013
-
Adaptimmune Ltd. Announces Exclusive License With Life Technologies on Proprietary Manufacturing Process for T Cell Therapy Using Its Modified T Cell Receptors
1/7/2013
-
Adaptimmune Ltd. Announces Preliminary Results From an Early Phase Trial of Gene Engineered T Cells Targeting Cancer Testis Antigens in Multiple Myeloma
12/13/2012
-
Adaptimmune Ltd. Announces Preliminary Results From an Early Phase Trial of Gene Engineered T Cells Targeting Cancer Testis Antigens in Multiple Myeloma
12/11/2012
-
Investigators to Present Preliminary Findings for Adaptimmune Ltd.'s Gene Engineered T Cells in Myeloma at the Annual American Society of Hematology Meeting on Monday 10 December
11/16/2012
-
Adaptimmune Ltd. Announces New Board Appointments as Clinical Programmes Get Underway
9/19/2011
-
Adaptimmune Ltd. Announces Opening of Pilot Clinical Trial in Synovial Sarcoma
7/25/2011
-
Adaptimmune Ltd. Announces Opening of Phase I/II Clinical Trial for Metastatic Melanoma
6/13/2011